Is AdaptHealth (AHCO) overvalued or fairly valued?

MarketChacha shows AdaptHealth's valuation in context — a trailing P/E of about 121.4, a forward P/E of about 9.4, a price-to-book of about 1.0 — alongside its revenue and profit growth and whether reported profit converts into operating cash, so you can judge value for yourself. MarketChacha does not issue ratings, price targets, or buy/sell advice.

What is AdaptHealth's revenue?

AdaptHealth reported revenue of $3.2B for FY2025, with net profit of $-70.8M, per official filings.

What is the share price of AdaptHealth (AHCO)?

AdaptHealth last traded at $10.93 (-2.5% on the day), as of 7/22/2026 — a delayed quote shown for education, not investment advice.

AdaptHealth

AHCO · NYSE · Healthcare · United States

$10.93-2.5%

Delayed · as reported by Yahoo Finance · as of Jul 22, 2026, 7:34 PM

Snapshot

TickerAHCO

ExchangeNYSE

SectorHealthcare

IndustryMedical Devices

CountryUnited States

Employees10,900

HeadquartersConshohocken, United States

Market cap$1.5B

P/E (TTM)121.4

P/B1.0

Volume557.3K

Websiteadapthealth.com

Filings tracked8

About AdaptHealth

AdaptHealth Corp., together with its subsidiaries, distributes home medical equipment (HME), medical supplies, and home and related services in the United States. It operates through Sleep Health, Respiratory Health, Diabetes Health, and Wellness at Home segments. The company offers sleep therapy equipment, supplies, and related services, such as continuous positive airway pressure and BiLevel services to individuals suffering from obstructive sleep apnea; oxygen and home mechanical ventilation equipment and supplies and related chronic therapy services; and medical devices, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; and other HME devices and supplies. It also provides PAP machines, wheelchairs, hospital beds, oxygen concentrators, ventilators, insulin pumps, diabetes management and wound care supplies, orthopedic bracing, breast pumps and supplies, walkers, commodes, enteral supplies, and incontinence supplies. The company services beneficiaries of Medicare, Medicaid, and commercial insurance payors. AdaptHealth Corp. was founded in 2012 and is headquartered in Conshohocken, Pennsylvania.

Profile as reported by Yahoo Finance.

Who owns it

Insiders8.1%
Institutions91.9%
Public & other0.0%

336 institutional holders

As reported by Yahoo Finance.

Top holders

OEP Capital Advisors, LP11.99%
Blackrock Inc.11.72%
Deerfield Management Company, L.P8.44%
Skyknight Capital, L.p.6.31%
FMR, LLC5.92%
Reinhart Partners, LLC5.45%
Dimensional Fund Advisors LP5.09%
Vanguard Portfolio Management LLC4.49%

Largest institutional holders, as reported by Yahoo Finance (as of 3/31/2026).

Forensic scorecard

Latest ROE of -4.7% is on the low side — the business earns a modest return on shareholder capital.

Net margin trend-21.2% → -2.2%

Margin has expanded by about 19.0 points — the business is getting more profitable.

Return on equity-4.7%

Latest ROE of -4.7% is on the low side — the business earns a modest return on shareholder capital.

Computed by MarketChacha from reported figures (SEC XBRL). Education, not a rating or recommendation.

What's expected next

Next quarter

Rev $886.2M · EPS 0.34

Est. earnings growth +45.7%

Next fiscal year

Rev $3.7B · EPS 1.17

Est. earnings growth +30.7%

Analyst consensus estimates — not the company's own guidance. As reported by Yahoo Finance.

$8.5152-wk range$13.43

Delayed · as reported by Yahoo Finance

New to these terms?

P/E ROE ROCE Margins Market cap

Browse the Learn hub →

Financials at a glance

Source: SEC XBRL

Annual

Quarterly · last 8

Market cap

$1.5B

Day change

-2.5%

P/E (TTM)

121.4

Fwd P/E

9.4

P/B

1.0

Beta

1.45

Revenue (FY2025)

$3.2B

Net margin

-2.2%

ROE

-4.7%

Revenue CAGR (2y)

+0.7%

EPS (FY2025)

-0.52

Net profit (FY2025)

$-70.8M

Market figures: Delayed · as reported by Yahoo Finance. Financials as reported in company filings.

Ask MarketChacha about AHCO

Get a cited, plain-English answer — the “why”, not just data. Finance research only, never buy/sell advice.

Financials

Yearly

Period	Revenue	Net profit	EPS	Net margin	ROE
FY2025	$3.2B	$-70.8M	-0.52	-2.2%	-4.7%
FY2024	$3.3B	$90.4M	0.61	2.8%	5.8%
FY2023	$3.2B	$-678.9M	-5.31	-21.2%	-46.5%

Quarterly

Period	Revenue	Net profit	EPS	Net margin
2026Q1	$819.8M	$-16.0M	-0.12	-2.0%
2025Q3	$820.3M	$24.5M	0.16	3.0%
2025Q2	$800.4M	$14.7M	0.10	1.8%
2025Q1	$777.9M	$-7.2M	-0.05	-0.9%
2024Q3	$805.9M	$22.9M	0.15	2.8%
2024Q2	$806.0M	$19.4M	0.13	2.4%
2024Q1	$792.5M	$-2.1M	-0.02	-0.3%
2023Q3	$804.0M	$-454.1M	-3.43	-56.5%
2023Q2	$793.3M	$14.0M	0.09	1.8%
2023Q1	$744.6M	$15.7M	-0.06	2.1%

Figures as reported, in reporting currency. Source: SEC XBRL.

Filings & announcements

2026

8-K — Material agreement, Exhibits
SEC7/20/2026material
8-K — Reg FD disclosure
SEC7/7/2026material
8-K filing
SEC7/2/2026material
8-K — Shareholder vote results
SEC6/22/2026material
8-K/A — Executive/director change, Exhibits
SEC6/2/2026
8-K — Results of operations, Executive/director change, Exhibits
SEC5/5/2026material
10-Q filing
SEC5/5/2026
8-K — Material agreement, Termination of agreement, Material financial obligation, Reg FD disclosure, Exhibits
SEC4/13/2026material

In the news

Education and discussion only — not investment advice. Financials from official filings (SEC/BSE) and reported company statements; market figures (delayed · as reported by yahoo finance) are delayed and shown for reference only. Verify with the linked sources before acting.